Skip to content
Screener

Corvel CRVL Total Liabilities & Equity

Total Liabilities & Equity at other companies

Arthur J. Gallagher logo
Arthur J. GallagherAJG
$81.81B+2.1%
Evolent Health, Inc. logo
Evolent Health, Inc.EVH
$1.97B-19.9%
Claritev Corporation logo
Claritev CorporationCTEV
$4.76B-6.1%
CareCloud, Inc. logo
CareCloud, Inc.CCLD
$93.85M+24.7%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$98.66M-5.4%
Cencora logo
CencoraCOR
$83.81B+13.3%

Other financials

Income statement

See full
Revenue$259.9M+10.7%
Gross profit$67.8M+19.4%
Net income$32.2M+18.3%
EPS (diluted)$0.63+21.2%

Balance sheet

See full
Cash & equivalents$255.9M+26.7%
Total debt$28.4M+3.6%
Total equity$408.9M+19.4%
Total assets$689.7M+15.4%

Cash flow

See full
Operating cash flow$49.9M-9.3%
CapEx$6.8M-55.8%
Free cash flow$43.1M+8.9%

Valuation

See full
Market cap$3.19B-28.9%
Enterprise value$2.96B-31.3%
P/E27.7×-16.8×
P/S3.2×-1.6×

Profitability

See full
Gross margin24.8%+1.0pp
Net margin11.7%+0.7pp
FCF margin11.6%+0.9pp

Returns & leverage

See full
Return on equity30.7%-2.6pp
Debt / equity0.1×0.0×
Current ratio1.9×+0.1×

Where this comes from

Reported directly by Corvel in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The source filing: Corvel’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:30 PM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0001193125-26-338216
Line itemJune 30, 2026March 31, 2026
Commitments and contingencies
Stockholders' Equity
Common stock, $0.0001 par value: 360,000,000 shares authorized at June 30, 2026 and March 31, 2026; 166,232,817 shares issued (50,596,284 shares outstanding, net of Treasury shares) and 166,168,732 shares issued (50,909,297 shares outstanding, net of Treasury shares) at June 30, 2026 and March 31, 2026, respectively5,0005,000
Paid-in capital272,917,000268,513,000
Treasury stock (115,636,533 shares at June 30, 2026 and 115,259,435 shares at March 31, 2026)(909,684,000)(887,716,000)
Retained earnings1,045,654,0001,013,429,000
Total stockholders' equity408,892,000394,231,000
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY$689,735,000$642,986,000

ITEM 1 – FINANCIAL STATEMENTS

FAQ

What is Corvel's total liabilities & equity?
Corvel (CRVL) reported total liabilities & equity of $689.74M in Q2 2026.
How has Corvel's total liabilities & equity changed year-over-year?
Corvel's total liabilities & equity increased by 15.4% year-over-year, from $597.45M to $689.74M.
What is the long-term trend for Corvel's total liabilities & equity?
Over 5 years (2021 to 2026), Corvel's total liabilities & equity has grown at a 8.6% compound annual growth rate (CAGR), from $424.76M to $642.99M.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Ask your AI about Corvel's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude